194 related articles for article (PubMed ID: 26558278)
1. The Selectivity of CK2 Inhibitor Quinalizarin: A Reevaluation.
Cozza G; Venerando A; Sarno S; Pinna LA
Biomed Res Int; 2015; 2015():734127. PubMed ID: 26558278
[TBL] [Abstract][Full Text] [Related]
2. Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.
Cozza G; Mazzorana M; Papinutto E; Bain J; Elliott M; di Maira G; Gianoncelli A; Pagano MA; Sarno S; Ruzzene M; Battistutta R; Meggio F; Moro S; Zagotto G; Pinna LA
Biochem J; 2009 Jul; 421(3):387-95. PubMed ID: 19432557
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells.
Franchin C; Cesaro L; Salvi M; Millioni R; Iori E; Cifani P; James P; Arrigoni G; Pinna L
Biochim Biophys Acta; 2015 Jun; 1854(6):609-23. PubMed ID: 25278378
[TBL] [Abstract][Full Text] [Related]
4. ATP site-directed inhibitors of protein kinase CK2: an update.
Sarno S; Papinutto E; Franchin C; Bain J; Elliott M; Meggio F; Kazimierczuk Z; Orzeszko A; Zanotti G; Battistutta R; Pinna LA
Curr Top Med Chem; 2011; 11(11):1340-51. PubMed ID: 21513497
[TBL] [Abstract][Full Text] [Related]
5. Biochemical characterization of CK2alpha and alpha' paralogues and their derived holoenzymes: evidence for the existence of a heterotrimeric CK2alpha'-holoenzyme forming trimeric complexes.
Olsen BB; Rasmussen T; Niefind K; Issinger OG
Mol Cell Biochem; 2008 Sep; 316(1-2):37-47. PubMed ID: 18574672
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel potent, selective and cell permeable inhibitor of protein kinase CK2 from the NIH/NCI Diversity Set Library.
Guerra B; Hochscherf J; Jensen NB; Issinger OG
Mol Cell Biochem; 2015 Aug; 406(1-2):151-61. PubMed ID: 25963666
[TBL] [Abstract][Full Text] [Related]
7. Proteomics perturbations promoted by the protein kinase CK2 inhibitor quinalizarin.
Franchin C; Salvi M; Arrigoni G; Pinna LA
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1676-86. PubMed ID: 25882195
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction.
Laudet B; Barette C; Dulery V; Renaudet O; Dumy P; Metz A; Prudent R; Deshiere A; Dideberg O; Filhol O; Cochet C
Biochem J; 2007 Dec; 408(3):363-73. PubMed ID: 17714077
[TBL] [Abstract][Full Text] [Related]
9. Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases.
Cozza G; Sarno S; Ruzzene M; Girardi C; Orzeszko A; Kazimierczuk Z; Zagotto G; Bonaiuto E; Di Paolo ML; Pinna LA
Biochim Biophys Acta; 2013 Jul; 1834(7):1402-9. PubMed ID: 23360763
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight.
Lolli G; Cozza G; Mazzorana M; Tibaldi E; Cesaro L; Donella-Deana A; Meggio F; Venerando A; Franchin C; Sarno S; Battistutta R; Pinna LA
Biochemistry; 2012 Aug; 51(31):6097-107. PubMed ID: 22794353
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 4,5,6,7-tetrahalogeno-1H-isoindole-1,3(2H)-diones as inhibitors of human protein kinase CK2.
Golub AG; Yakovenko OY; Prykhod'ko AO; Lukashov SS; Bdzhola VG; Yarmoluk SM
Biochim Biophys Acta; 2008 Jan; 1784(1):143-9. PubMed ID: 18021749
[TBL] [Abstract][Full Text] [Related]
12. The selectivity of inhibitors of protein kinase CK2: an update.
Pagano MA; Bain J; Kazimierczuk Z; Sarno S; Ruzzene M; Di Maira G; Elliott M; Orzeszko A; Cozza G; Meggio F; Pinna LA
Biochem J; 2008 Nov; 415(3):353-65. PubMed ID: 18588507
[TBL] [Abstract][Full Text] [Related]
13. A subnanomolar fluorescent probe for protein kinase CK2 interaction studies.
Enkvist E; Viht K; Bischoff N; Vahter J; Saaver S; Raidaru G; Issinger OG; Niefind K; Uri A
Org Biomol Chem; 2012 Nov; 10(43):8645-53. PubMed ID: 23032938
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase CK2 is necessary for the adipogenic differentiation of human mesenchymal stem cells.
Schwind L; Wilhelm N; Kartarius S; Montenarh M; Gorjup E; Götz C
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2207-16. PubMed ID: 26025678
[TBL] [Abstract][Full Text] [Related]
15. Conformational plasticity of the catalytic subunit of protein kinase CK2 and its consequences for regulation and drug design.
Niefind K; Issinger OG
Biochim Biophys Acta; 2010 Mar; 1804(3):484-92. PubMed ID: 19796713
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of 2,6-di(furan-3-yl)anthracene-9, 10-dione as an inhibitor of human protein kinase CK2.
Haidar S; Meyers A; Bollacke A; Jose J
Pharmazie; 2015 Dec; 70(12):772-6. PubMed ID: 26817273
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase CK2 regulates metal toxicity in neuronal cells.
Zaman MS; Johnson AJ; Bobek G; Kueh S; Kersaitis C; Bailey TD; Buskila Y; Wu MJ
Metallomics; 2016 Jan; 8(1):82-90. PubMed ID: 26623569
[TBL] [Abstract][Full Text] [Related]
18. Structure of human protein kinase CK2 alpha 2 with a potent indazole-derivative inhibitor.
Nakaniwa T; Kinoshita T; Sekiguchi Y; Tada T; Nakanishi I; Kitaura K; Suzuki Y; Ohno H; Hirasawa A; Tsujimoto G
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Feb; 65(Pt 2):75-9. PubMed ID: 19193990
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory influence of natural flavonoids on human protein kinase CK2 isoforms: effect of the regulatory subunit.
Baier A; Nazaruk J; Galicka A; Szyszka R
Mol Cell Biochem; 2018 Jul; 444(1-2):35-42. PubMed ID: 29188536
[TBL] [Abstract][Full Text] [Related]
20. The role of the N-terminal domain in the regulation of the "constitutively active" conformation of protein kinase CK2α: insight from a molecular dynamics investigation.
Cristiani A; Costa G; Cozza G; Meggio F; Scapozza L; Moro S
ChemMedChem; 2011 Jul; 6(7):1207-16. PubMed ID: 21591262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
